MedPath

Xellia Pharmaceuticals ApS

Xellia Pharmaceuticals ApS logo
🇩🇰Denmark
Ownership
Private
Established
1903-01-01
Employees
1K
Market Cap
-
Website
http://www.xellia.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

14

NMPA:6
CIMA_AEMPS:5
FDA:3

Drug Approvals

Polymyxin B Sulfate for Injection

Product Name
注射用硫酸多粘菌素B
Approval Number
国药准字HJ20250039
Approval Date
Apr 8, 2025
NMPA

Amphotericin B

Product Name
两性霉素 b
Approval Number
H20160687
Approval Date
Dec 22, 2016
NMPA

Amphotericin B

Product Name
两性霉素 b
Approval Number
H20160686
Approval Date
Dec 22, 2016
NMPA

Polymyxin B Sulfate

Product Name
硫酸多黏菌素 b
Approval Number
H20140249
Approval Date
Apr 6, 2014
NMPA

Polymyxin B Sulfate

Product Name
硫酸多黏菌素 b
Approval Number
H20140248
Approval Date
Apr 6, 2014
NMPA

Polymyxin B Sulfate

Product Name
硫酸多粘菌素 b
Approval Number
H20130947
Approval Date
Dec 25, 2013
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.